C4 Therapeutics, Inc. (CCCC)
4.10
+0.10
(+2.50%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.03
(-0.73%)
After-Hours: 20:00
C4 Therapeutics Market Cap : 503.91M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 503.91M |
| August 21, 2026 | 491.62M |
| August 20, 2026 | 495.31M |
| August 19, 2026 | 517.43M |
| August 18, 2026 | 513.75M |
| August 17, 2026 | 524.19M |
| August 14, 2026 | 521.12M |
| August 13, 2026 | 501.46M |
| August 12, 2026 | 479.33M |
| August 11, 2026 | 475.65M |
| August 10, 2026 | 444.92M |
| August 07, 2026 | 458.44M |
| August 06, 2026 | 447.38M |
| August 05, 2026 | 376.61M |
| August 04, 2026 | 375.57M |
| August 03, 2026 | 364.13M |
| July 31, 2026 | 362.05M |
| July 30, 2026 | 380.77M |
| July 29, 2026 | 366.21M |
| July 28, 2026 | 369.33M |
| July 27, 2026 | 373.49M |
| July 24, 2026 | 353.72M |
| July 23, 2026 | 379.73M |
| July 22, 2026 | 389.10M |
| July 21, 2026 | 398.46M |
| Date | Value |
|---|---|
| July 20, 2026 | 372.45M |
| July 17, 2026 | 383.89M |
| July 16, 2026 | 372.45M |
| July 15, 2026 | 395.34M |
| July 14, 2026 | 396.38M |
| July 13, 2026 | 407.82M |
| July 10, 2026 | 422.39M |
| July 09, 2026 | 446.32M |
| July 08, 2026 | 435.91M |
| July 07, 2026 | 452.56M |
| July 06, 2026 | 430.71M |
| July 02, 2026 | 447.36M |
| July 01, 2026 | 451.52M |
| June 30, 2026 | 485.85M |
| June 29, 2026 | 452.56M |
| June 26, 2026 | 443.20M |
| June 25, 2026 | 457.76M |
| June 24, 2026 | 442.15M |
| June 23, 2026 | 439.03M |
| June 22, 2026 | 428.63M |
| June 18, 2026 | 431.75M |
| June 17, 2026 | 407.82M |
| June 16, 2026 | 399.50M |
| June 15, 2026 | 397.42M |
| June 12, 2026 | 405.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cartesian Therapeutics, Inc. | 302.18M |
| Beam Therapeutics, Inc. | 2.925B |
| Rallybio Corp. | 89.16M |
| Q32 Bio, Inc. | 388.33M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
Market Cap Related Metrics
| PS Ratio | 13.05 |
| Price to Book Value | 2.038 |
| Price | 4.10 |
| Earnings Yield | -24.36% |